ELAB expands AI drug discovery partnership with Yuva Biosciences
ELAB said it expanded its AI-driven drug discovery program with Yuva Biosciences, advancing four AI-discovered compounds toward lead nomination for cardiac disease and obesity therapeutic applications.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.